Benjamin F. Edwards & Company’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $16K | Hold |
900
| – | – | ﹤0.01% | 1597 |
|
|
2024
Q1 | $14K | Hold |
900
| – | – | ﹤0.01% | 1622 |
|
|
2023
Q4 | $15K | Hold |
900
| – | – | ﹤0.01% | 1561 |
|
|
2023
Q3 | $8K | Hold |
900
| – | – | ﹤0.01% | 1455 |
|
|
2023
Q2 | $22K | Hold |
900
| – | – | ﹤0.01% | 1256 |
|
|
2023
Q1 | $14K | Hold |
900
| – | – | ﹤0.01% | 1348 |
|
|
2022
Q4 | $11K | Hold |
900
| – | – | ﹤0.01% | 1411 |
|
|
2022
Q3 | $5K | Hold |
900
| – | – | ﹤0.01% | 1568 |
|
|
2022
Q2 | $4K | Sell |
900
-1,000
| -53% | -$4.44K | ﹤0.01% | 1597 |
|
|
2022
Q1 | $18K | Sell |
1,900
-6,240
| -77% | -$59.1K | ﹤0.01% | 1256 |
|
|
2021
Q4 | $155K | Buy |
8,140
+2,100
| +35% | +$40K | 0.01% | 764 |
|
|
2021
Q3 | $201K | Buy |
6,040
+2,768
| +85% | +$92.1K | 0.01% | 653 |
|
|
2021
Q2 | $127K | Buy |
3,272
+1,972
| +152% | +$76.5K | 0.01% | 778 |
|
|
2021
Q1 | $63K | Buy |
1,300
+1,000
| +333% | +$48.5K | ﹤0.01% | 946 |
|
|
2020
Q4 | $16K | Sell |
300
-200
| -40% | -$10.7K | ﹤0.01% | 1193 |
|
|
2020
Q3 | $13K | Sell |
500
-500
| -50% | -$13K | ﹤0.01% | 1215 |
|
|
2020
Q2 | $19K | Hold |
1,000
| – | – | ﹤0.01% | 1151 |
|
|
2020
Q1 | $10K | Buy |
+1,000
| New | +$10K | ﹤0.01% | 1259 |
|